Educational Objectives: By the end of the activity, participants will be able to:

1. Identify and apply the best treatment options for patients with neurovascular diseases (i.e aneurysms, AVM, DAVF, Moya-moya, carotid stenosis), using evidence-based practices and expert consensus. Provide recommendations for age-specific related treatment specific to the age and geriatric population as applicable.
2. Integrate cultural competency into the discussions that will assist in integrating the attitudes, evidence-based treatment recommendations and skills that enables a health care professional to care effectively for patients from diverse cultures, groups and communities.
3. Transfer the evidence-based treatment recommendations of individual practitioners through collaboration of case management.
4. Align with regional KPHC Initiatives and Comprehensive Stroke Center.

Target Audience:

Physician Focus: Neurosurgeons, Interventional Neuro- Radiologists. Interventional Radiologists, Neurointensivists, Neuroscience
Non-Physician Professionals: Neuroscience NP, Interventional Neuro NP, Stroke Coordinator

KP Planners/Faculty (varies): 

KP Faculty (Varies): KP CME Staff:

1. Julia Carranza, CME Coordinator
2. Alvin Ting, MD, COE

Resources:

1. ^{AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage  1 sahguidelines09.pdf}
2. ^{AHA/ASA Guidelines for the Prevention & Management of Stroke  2 CR_StrokeRecommendations_References_2015_Final.pdf}
3. ^{The New England Journal of Medicine, A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke, January 1, 2015, N Engl J Med 2015;372:11-20. DOI: 10.1056/NEJMoa1411587  3 ESTMRCLEAN_0.pdf}
4. ^{Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 2014;383:614 –21 Mohr JP, Parides MK, Stapf C, et al. 4 aribalancet_4.pdf}
5. ^{International Study of Unruptured Intracranial Aneurysms (ISUIA), Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment, THE LANCET • Vol 362 • July 12, 2003  5 lancetISUIA2003_0.pdf}
6. ^{Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial, Lancet 2014; 383: 333–41 6 sammprisfinal_0.pdf}

Disclosure Statement (as appropriate): None of the planners, faculty, committee members or reviewers for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patient.

Kaiser Permanente Medical Center - Redwood City takes responsibility for the content, quality and scientific integrity of this CME Activity.

Kaiser Permanente does not endorse any brand -name products.

Accreditation Statement:

Kaiser Permanente Permanente Medical Center - Redwood City is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians

The Kaiser Permanente Medical Center - Redwood City designates this Live Activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.